Founded in 1997, Dechra Pharmaceuticals, based in Stoke-on-Trent, manufactures an expansive range of products for the veterinary market. The company was first listed on the London Stock Exchange in 2000 and is globally respected as one of the market leaders. Dechra is committed to the care of your animals, in particular dogs, cats and horses, and is constantly innovating to bring you the most targeted and effective products achievable. With many successes under its belt, including Vetoryl, the only licensed treatment for hyperadrenocorticism in dogs, Felimazole and Thyforon, the company is expanding fast and looking to develop on its product range. Feel free to browse our inclusive list of Dechra pharmaceuticals.